Latest Industry Projects

Our List of Pharmaceutical Projects helps to drive insights-driven action and Pharma execution for superior ROI and they include Pharmaceutical Industry Featured Projects, Upcoming Projects in Pharmaceutical and so on. We provide Global Pharmaceuticals Industry Projects to our clients to ensure efficiencies and effectiveness in their business efforts. Moreover, Pharmaceutical Industry projects leverage cross-channel integration to engage the consumers, generate insights, and measure business value.

SCHOTT Plans To Build State-Of-The-Art High-Quality Pharmaceutical Glass Tubing Plant In China

Introduction: The international technology group SCHOTT plans to build State-Of-The-Art greenfield pharmaceutical glass tubing plant in Jinyun, Zhejiang. Features: The new plant will enable SCHOTT to participate in the advancement of the Chinese pharmaceutical packaging industry. SCHOTT will invest 60 million Euros in the first phase to install a yearly…

Pfizer Invests $500 Million To Advance State-Of-The-Art Gene Therapy Facility In Sanford, North Carolina

Introduction: Pfizer invests $500 Million for the construction of its state-of-the-art gene therapy manufacturing facility in Sanford, North Carolina. Features: By expanding its manufacturing footprint in Sanford, Pfizer expects to strengthen its ability to produce and supply both clinical- and commercial-scale quantities of critical, potentially life-changing gene therapy medicines to…

Tergus Pharma to Build a New Commercial Manufacturing Facility with Great Point Partners

Introduction: Tergus Pharma partners with Great Point Partners to build a new commercial manufacturing facility. Features: A 100,000 square feet new expansion will provide comprehensive services from development through manufacturing and will become a Contract Development and Manufacturing Organisation, or CDMO. The new US$ 35million facility will be provide an…

Intertek to Expand Pharmaceutical Services Facility in Melbourn

Introduction: Intertek announced the expansion of its pharmaceutical services laboratory in Melbourn, near Cambridge, through the acquisition of a new 20,000 sq. ft facility. Features: The current facility provides pharmaceutical analysis and formulation development services, with specialist expertise in orally inhaled and nasal drug products. It is located adjacent to…

Merck Announces Expansion of Manufacturing Facility with US$165 million investment

Introduction: Merck announced an investment of US$165 million in its manufacturing site at Aubonne, Switzerland, to expand its production of biotech medicines. Features: The new building will be equipped with cutting-edge technologies dedicated to aseptic filling and quality control, with an innovative design and a flexible operations model to deliver…

Amgen to Construct Next-generation Biomanufacturing Plant with US$200 million in Rhode Island

Introduction: Amgen announced the groundbreaking of its new next-generation biomanufacturing plant with US$200 million at its West Greenwich, Rhode Island (USA) campus. Features: The new plant will use Amgen’s proven next-generation biomanufacturing capabilities. A next-generation biomanufacturing plant incorporates multiple innovative technologies into a single facility. The plant requires a smaller…

Sterling Pharma Solutions to Invest US$8 million in Pilot Plant Facility at its UK Site

Introduction: Contract Development and Manufacturing Organisation (CDMO), Sterling Pharma Solutions is investing US$8 million into its pilot plant facility at its UK site. Features: The facility will enhance the pilot plant’s capacity by 33 per cent and increase the site’s production capabilities and flexibility for small to mid-scale batch production.…

Ferring Announces US$30 million Expansion Plan of New Biotech Centre in Switzerland

Introduction: Ferring Pharmaceuticals made a US$30 million investment announcement of expanding its capabilities in biologics through a new biotech centre at its global headquarters and manufacturing site in St Prex, Switzerland. Features: Ferring Pharmaceuticals is planning to integrate discovery and development capabilities for monoclonal antibodies as well as biologics manufacturing…

Sangamo Plans For New Headquarters In Brisbane, California

Introduction: Sangamo Therapeutics, Inc. plans for new corporate headquarters at 7000 Marina Boulevard, an 88,000 square foot building at Oyster Point in Brisbane, California, in the heart of the biotech hub south of San Francisco. Features: In addition to laboratories, workstations and collaboration spaces, Sangamo will construct on-site in Brisbane…

 Sanofi to invest €170 million in new vaccine production facility in France

Introduction: Sanofi to invest €170 million to expand a vaccine manufacturing site in Val de Reuil, France. The expansion further strengthens Sanofi’s position as one of the world’s leading seasonal flu vaccine providers. Features: The new facility will allow Sanofi Pasteur, the Vaccines global business unit of Sanofi, to expand…

loadmore..